1. Home
  2. QH vs LGVN Comparison

QH vs LGVN Comparison

Compare QH & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QH

Quhuo Limited American Depository Shares

SELL

Current Price

$3.23

Market Cap

8.0M

ML Signal

SELL

Logo Longeveron Inc.

LGVN

Longeveron Inc.

SELL

Current Price

$2.15

Market Cap

7.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
QH
LGVN
Founded
2012
2014
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
7.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
QH
LGVN
Price
$3.23
$2.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
2.3K
★ 90.9K
Earning Date
11-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.76
EPS
★ N/A
N/A
Revenue
N/A
★ $709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$24.63
P/E Ratio
$2.86
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.07
$0.48
52 Week High
$12.81
$7.60

Technical Indicators

Market Signals
Indicator
QH
LGVN
Relative Strength Index (RSI) 49.46 49.56
Support Level $3.05 $0.65
Resistance Level $4.07 $7.30
Average True Range (ATR) 0.11 0.27
MACD 0.05 0.14
Stochastic Oscillator 69.84 37.17

Price Performance

Historical Comparison
QH
LGVN

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: